Robert Yarchoan
9Patents
6h-index
28Co-inventors
63Inventor score
Filing activity: Apr 19, 1985 → Jun 24, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5026687A | Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds | Human Necessities | 95 | Expired |
| US5665345A | Methods of inhibiting viral replication using IL-10 | Human Necessities | 23 | Expired |
| US4707443A | Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6423308B1 | Treatment of Kaposi's sarcoma with IL-12 | Human Necessities | 14 | Expired |
| US5376642A | Treatment of retroviral induced dementia by administration of 2',3'-dideoxyinosine | Human Necessities | 13 | Expired |
| US6509321B1 | Treatment of Kaposi's sarcoma with IL-12 | Human Necessities | 6 | Expired |
| US5616566A | Method of inhibiting HIV replication with 2',3'-dideoxyadenosine | Human Necessities | 5 | Expired |
| US10001483B2 | Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers | Physics | 0 | Active |
| US9474793B2 | Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.